Back to Trials
NCT06053645Recruiting

The Weight of Cardiovascular Disease

Mayo Clinic

Start Date

4/22/2024

Completion Date

7/1/2026

Summary

The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * BMI ≥30 kg/m2 * At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF (heart failure with reduced ejection fraction), ACHD (adult congenital heart disease), or valvular heart disease * Patients evaluated in the Cardiometabolic clinic * Willingness to complete questionnaires/surveys * Ability to complete monthly self-assessments at home Exclusion Criteria: * BMI \<30 kg/m2 * Pregnancy or lactating women * Hemodynamically unstable CVD * Active malignancy * Autoimmune or systemic inflammatory diseases * Severe renal or hepatic failure * Being considered unsafe to participate as determined by the study physician * Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic medications, or other medications as determined by the study NP or physician * Patients with active psychosis, mania, or substance use disorders

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cardiovascular DiseasesObesity

Locations

Mayo Clinic in Rochester

Rochester, Minnesota 55905

United States